Pharma Journalist -

Astellas Pharma Inc. announced that it will invest nearly $13 million into two innovation incubators operated by LabCentral, a premier United States-based laboratory facility for…
Read More...

Elligo Health Research, a healthcare-enabling research organization, has received a grant from the U.S. Food and Drug Administration (FDA) for a follow-on project to extend the value of…
Read More...

Cellectis and Lonza announced that the companies have entered into a manufacturing service agreement covering clinical manufacturing of Cellectis’ allogeneic UCART product candidates…
Read More...

SMi Reports: Registration is open for Europe’s only Parallel Trade conference and exhibition taking place in February 2020 in London. SMi is delighted to announce the highly…
Read More...

Novartis announced an important step in reimagining medicine by founding the Novartis AI innovation lab and by selecting Microsoft Corp. as its strategic AI and data-science partner for…
Read More...

Servier announced the acquisition of PIXUVRI from CTI BioPharma. PIXUVRI is a treatment for adult patients with multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphoma.…
Read More...

Chimerix announces an exclusive global license agreement with SymBio Pharmaceuticals, Ltd (SymBio), under which SymBio has exclusively licensed the worldwide rights to develop,…
Read More...

Ocugen, Inc. a clinical stage biopharmaceutical company focused on innovative therapies that address rare and underserved eye diseases, has entered into a strategic partnership with…
Read More...

Moberg Pharma AB has signed an exclusive license agreement with Taisho Pharmaceutical Co., Ltd for development, registration and commercialization of MOB-015 in Japan. Under the…
Read More...

Swedish Orphan Biovitrum AB (publ) (Sobi) announced a definitive agreement to acquire Dova Pharmaceuticals, Inc. by means of a tender offer. The consideration consists of an upfront…
Read More...